$WRAP Cashflow Statement | Understand Stock

$WRAP

$1.15 -$0.07 (5.74%) Close

$WRAP Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash Flows From Operating Activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Write off of intangibles
Impairment of goodwill and intangibles
Loss on disposition of assets
Share-based compensation
Common shares issued for services
Product line exit expense
Debt forgiveness income
Warranty provision
Software impairment charge
Change in contingent liability
Change in fair value of warrant liabilities
Non-cash lease expense
Non-cash interest expense
Provision for credit losses
Write off of accounts receivable
Inventory obsolescence reserve

Changes in assets and liabilities:
Accounts receivable
Inventories
Prepaid expenses and other current assets
Accounts payable
Operating lease liabilities
Customer deposits
Accrued liabilities and other
Warranty settlement
Deferred revenue
Other non-current assets
Net cash used in operating activities
Cash Flows From Investing Activities:
Purchases of short-term investments
Proceeds from maturities of short-term investments
Capital expenditures for property and equipment
Investment in patents, trademarks, and other intangibles
Patents and Trademarks
Intangibles Other than Patents and Trademarks
Total investment in patents, trademarks, and other intangibles
Business acquisition
Net cash paid for acquisition of Intrensic
Proceeds from long-term deposits
Net cash (used in) provided by investing activities

Cash Flows From Financing Activities:
Sale of common stock and warrants
Offering costs paid on sale of common stock and warrants
Proceeds from exercise of warrants
Offering costs paid on exercise of warrants
Proceeds from exercise of stock options
Proceeds from bank note
Repayment of debt
Proceeds from issuance of warrants and convertible preferred stock,
Proceeds from issuance of Series B convertible preferred stock
Proceeds from issuance of warrants and common stock, net of offering costs
Dividends settled in cash
Net cash provided by financing activities
Net (decrease) increase in cash and cash equivalents
Cash and cash equivalents, beginning of period
Cash and cash equivalents, end of period

Net decrease in cash and cash equivalents
Cash and cash equivalents, beginning of period
Cash and cash equivalents, end of period
Supplemental Disclosure of Non-Cash Investing and Financing Activities
Business acquisition liability
Business acquisition cost in deferred revenue
Change in unrealized gain on short-term investments
Right-of-use asset and liability recorded during period
Issuance of common stock for acquisition
Net assets acquired from acquisition
Reclassification of warrant liabilities to additional paid in capital
Dividends on convertible preferred stock
Dividends settled with common stock

Comments